Who owns VTGN?
Institutional ownership of Vistagen Therapeutics Inc. from Form 13F, Q2 2026
49 institutional managers reported holding Vistagen Therapeutics Inc. (VTGN) in Form 13F filings for Q2 2026, with 11,777,858 shares worth $2.7M. The largest reported holder was Commodore Capital LP. Managers that filed both quarters cut a net 3,570,361 shares (-23.3%). 10 opened new positions and 16 sold out.
- Funds holding
- 49
- Value held
- $2.7M
- New / sold out
- 10 / 16
- Net shares, same filers
- -23.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of VTGN
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Commodore Capital LP | $630K | 23.7% | 2,788,620 | New |
| Vanguard Capital Management LLC | $356K | 13.4% | 1,574,200 | Unchanged |
| Two Sigma Investments, LP | $192K | 7.2% | 847,992 | Added |
| Acadian Asset Management LLC | $178K | 6.7% | 794,579 | Added |
| Renaissance Technologies LLC | $165K | 6.2% | 730,500 | Added |
| Stempoint Capital LP | $139K | 5.2% | 616,749 | Trimmed |
| Ikarian Capital, LLC | $117K | 4.4% | 519,077 | Unchanged |
| AdvisorShares Investments LLC | $99K | 3.7% | 438,643 | Added |
| Luminus Management LLC | $91K | 3.4% | 403,115 | Added |
| Geode Capital Management, LLC | $83K | 3.1% | 365,002 | Trimmed |
| ADAR1 Capital Management, LLC | $79K | 3.0% | 351,141 | Trimmed |
| BlackRock, Inc. | $78K | 2.9% | 345,432 | Trimmed |
| Group One Trading LLC | $69K | 2.6% | 304,385 | Added |
| Verdad Advisers, LP | $66K | 2.5% | 293,343 | Added |
| Vanguard Fiduciary Trust Co | $49K | 1.8% | 217,700 | Unchanged |
| Jane Street Group, LLC | $37K | 1.4% | 164,827 | Trimmed |
| Boothbay Fund Management, LLC | $30K | 1.1% | 134,571 | Unchanged |
| State Street Corp | $27K | 1.0% | 121,114 | Unchanged |
| XTX Topco Ltd | $27K | 1.0% | 118,380 | Trimmed |
| Northern Trust Corp | $18K | 0.7% | 80,823 | Added |
| Citadel Advisors LLC | $16K | 0.6% | 68,839 | New |
| Virtu Financial LLC | $15K | 0.6% | 66,021 | New |
| UBS Group AG | $13K | 0.5% | 57,830 | Trimmed |
| Gsa Capital Partners LLP | $12K | 0.5% | 54,584 | Added |
| Osaic Holdings, Inc. | $10K | 0.4% | 43,888 | Added |
Share of 13F holdings is each fund's shares as a share of the 11,777,858 VTGN shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Commodore Capital LP New+$630K
- Renaissance Technologies LLC Added+$99K
- Two Sigma Investments, LP Added+$86K
- Group One Trading LLC Added+$64K
- Acadian Asset Management LLC Added+$46K
- AdvisorShares Investments LLC Added+$37K
- Verdad Advisers, LP Added+$25K
- Citadel Advisors LLC New+$16K
- Virtu Financial LLC New+$15K
- Osaic Holdings, Inc. Added+$9K
Biggest sellers in Q2 2026
- Orbimed Advisors LLC Sold out-$1.7M
- TCG Crossover Management, LLC Sold out-$1.5M
- Millennium Management LLC Sold out-$246K
- Stempoint Capital LP Trimmed-$139K
- ADAR1 Capital Management, LLC Trimmed-$90K
- Shay Capital LLC Sold out-$83K
- Susquehanna International Group, LLP Sold out-$82K
- Tudor Investment Corp Et Al Sold out-$61K
- Diadema Partners LP Sold out-$60K
- Prudential Financial Inc Sold out-$30K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $1.1M and sold $4.2M; 15 added and 14 trimmed.
Schedule 13D and 13G filings on VTGN
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-11-14ORBIMED ADVISORS LLC SCHEDULE 13G filed by Vistagen Therapeutics Inc.Schedule 13G
- 2025-09-08JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Vistagen Therapeutics Inc.Schedule 13G
Questions about VTGN ownership
- Who owns VTGN stock?
- 49 institutional investment managers reported VTGN positions in their Form 13F filings for Q2 2026, holding 11,777,858 shares worth $2.7M in total. Commodore Capital LP reported the largest position.
- Are funds buying or selling VTGN?
- In Q2 2026, 10 managers opened new VTGN positions, 15 added, 14 trimmed and 16 sold out. Managers that filed in both quarters sold a net 3,570,361 shares.
- How current is this VTGN institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to VTGN by CUSIP. Options are left out. VTGN news and filings · VTGN insider trades · Top funds